Back

Family history of Brugada syndrome is associated with increased risk of syncope, cardiac arrhythmias, and ICD-implantation

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Epidemiology and diagnostic aspects in ventricular arrhythmia Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Miss Isabelle Philippine Thierry

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Refined diagnostic understanding of arrhythmogenic cardiomyopathy in the modern era from overdiagnosis to diagnostic precision: the evolving diagnostic criteria for arrhythmogenic cardiomyopathy
Doctor N. Wainstejn (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Advancing age and male sex predict left ventricular outflow tract origin in idiopathic PVCs
Doctor M. Botis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Novel mapping array for transmural mapping of myocardial activation: proof of concept in electro-tomography
Doctor K. De Silva (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Socioeconomic and regional disparities in the diagnosis of primary arrhythmias in a universal healthcare system: A nation-wide danish study
Mr C. Hansen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Age threshold of ventricular arrhythmia in patients with Brugada syndrome
Associate Professor J. Uhm (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology and diagnostic aspects in ventricular arrhythmia

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Risk of inherited cardiac disease in relatives of out-of-hospital cardiac arrest patients - a nationwide study
thumbnail
Congress Presentation
Long-term performance of different treatment approaches in Brugada Syndrome
thumbnail
Congress Presentation
Prognosis of Brugada patients according to their SCN5A genetic status.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources